These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38381555)

  • 1. Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses.
    Shuptrine CW; Chen Y; Miriyala J; Lenz K; Moffett D; Nguyen TA; Michaux J; Campbell K; Smith C; Morra M; Rivera-Molina Y; Murr N; Cooper S; McGuire A; Makani V; Oien N; Zugates JT; de Silva S; Schreiber TH; de Picciotto S; Fromm G
    Cancer Res; 2024 May; 84(10):1550-1559. PubMed ID: 38381555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery.
    Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
    Bioengineered; 2021 Dec; 12(2):12383-12393. PubMed ID: 34895063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
    Meulewaeter S; Aernout I; Deprez J; Engelen Y; De Velder M; Franceschini L; Breckpot K; Van Calenbergh S; Asselman C; Boucher K; Impens F; De Smedt SC; Verbeke R; Lentacker I
    J Control Release; 2024 Jun; 370():379-391. PubMed ID: 38697317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines.
    Zhivaki D; Gosselin EA; Sengupta D; Concepcion H; Arinze C; Chow J; Nikiforov A; Komoroski V; MacFarlane C; Sullivan C; Kagan JC
    mBio; 2023 Dec; 14(6):e0250623. PubMed ID: 37937842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA-encoded, constitutively active STING
    Tse SW; McKinney K; Walker W; Nguyen M; Iacovelli J; Small C; Hopson K; Zaks T; Huang E
    Mol Ther; 2021 Jul; 29(7):2227-2238. PubMed ID: 33677092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput
    Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
    ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
    Takanashi A; Pouton CW; Al-Wassiti H
    Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
    Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma.
    Zhang Y; Xie F; Yin Y; Zhang Q; Jin H; Wu Y; Pang L; Li J; Gao J
    Int J Nanomedicine; 2021; 16():1553-1564. PubMed ID: 33658783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
    Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
    Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice.
    Ramos da Silva J; Bitencourt Rodrigues K; Formoso Pelegrin G; Silva Sales N; Muramatsu H; de Oliveira Silva M; Porchia BFMM; Moreno ACR; Aps LRMM; Venceslau-Carvalho AA; Tombácz I; Fotoran WL; Karikó K; Lin PJC; Tam YK; de Oliveira Diniz M; Pardi N; de Souza Ferreira LC
    Sci Transl Med; 2023 Mar; 15(686):eabn3464. PubMed ID: 36867683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model.
    Peng S; Tan M; Li YD; Cheng MA; Farmer E; Ferrall L; Gaillard S; Roden RBS; Hung CF; Wu TC
    Cancer Immunol Immunother; 2021 Apr; 70(4):1049-1062. PubMed ID: 33108473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy.
    Jiang Y; Zhang Y; Liu C; Liu J; Xue W; Wang Z; Li X
    J Control Release; 2024 Apr; 368():663-675. PubMed ID: 38492862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine.
    Tateshita N; Miura N; Tanaka H; Masuda T; Ohtsuki S; Tange K; Nakai Y; Yoshioka H; Akita H
    J Control Release; 2019 Sep; 310():36-46. PubMed ID: 31386869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy.
    Liu JQ; Zhang C; Zhang X; Yan J; Zeng C; Talebian F; Lynch K; Zhao W; Hou X; Du S; Kang DD; Deng B; McComb DW; Bai XF; Dong Y
    J Control Release; 2022 May; 345():306-313. PubMed ID: 35301053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity.
    de Silva S; Fromm G; Shuptrine CW; Johannes K; Patel A; Yoo KJ; Huang K; Schreiber TH
    Cancer Immunol Res; 2020 Feb; 8(2):230-245. PubMed ID: 31852716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.